Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTP0301 for Bowel Preparation
NCT05870553Phase 3Completed
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Start
- Jan 2023
- Primary completion
- May 2023
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Cleanview-All in bowel preparation (3 arms), sponsored by Taejoon Pharmaceutical Co., Ltd. Primary endpoint: Number of Patients With Successful Bowel Cleansing (Overall Colon) at 1 day. Started Jan 2023; status: completed.
02
Drugs
Cleanview-All
03
Conditions
bowel preparation
Beyond the preview
Go deeper on NCT05870553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05870553.